Syndax Pharmaceuticals Inc Banner Image

Syndax Pharmaceuticals Inc

  • Ticker SNDX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Syndax Pharmaceuticals Inc Logo Image
  • 51-200 Employees
  • Based in Waltham, Massachusetts
Syndax is a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies. Company lead product candidate, entinostat, which was granted Breakthrough Therapy designation by the FDA following positive results from our Phase 2b clinical trial, ENCORE 301, is currently being evaluated in a Phase 3 clinical trial for advanced hormone receptor positive, humanMore epidermal growth factor receptor 2 negative breast cancer.
4.8 / 5.0 (188)

Syndax Pharmaceuticals Inc reports have an aggregate usefulness score of 4.8 based on 188 reviews.

Syndax Pharmaceuticals Inc

Most Recent Annual Report

Syndax Pharmaceuticals Inc
MOST RECENT 2022 Annual Report and Form 10K

Syndax Pharmaceuticals Inc does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

Syndax Pharmaceuticals Inc Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!